CSPC Pharmaceutical Group... (CHJTF)

PNK: CHJTF · Real-Time Price · USD

0.64

0.02 (3.23%)

At close: May 01, 2025, 8:00 PM

CSPC Pharmaceutical Income Statement

Financials in HKD. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	17.5B	16.6B	7.78B	8.03B	8.05B	17.2B	18.85B	17B	16.59B	14.13B	13.89B	12.16B	12.92B	5.53B	5B	4.62B	4.62B	4.62B	4.01B	3.23B	3.23B	3.23B	3.1B	2.77B	2.77B
Cost of Revenue	4.97B	4.79B	2.23B	2.31B	2.53B	4.95B	5.16B	4.16B	3.96B	3.55B	3.48B	3.15B	3.89B	1.55B	1.61B	1.56B	1.56B	1.56B	1.58B	1.28B	1.28B	1.28B	1.5B	1.36B	1.36B
Gross Profit	12.52B	11.82B	5.55B	5.72B	5.52B	12.25B	13.69B	12.84B	12.63B	10.58B	10.41B	9.02B	9.03B	3.98B	3.39B	3.05B	3.05B	3.05B	2.43B	1.95B	1.95B	1.95B	1.6B	1.41B	1.41B
Operating Income	3.98B	3.79B	1.93B	1.91B	1.75B	3.73B	4.18B	3.79B	3.73B	3.34B	2.78B	2.44B	2.61B	1.16B	1.05B	1.01B	1.01B	1.01B	916.95M	727.48M	727.48M	727.48M	676.17M	596.49M	596.49M
Interest Income	n/a	145.93M	n/a	141.15M	n/a	161.64M	118.91M	131M	90M	87.39M	29.18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	4.08B	4.04B	1.93B	1.9B	1.78B	4.35B	4.49B	3.83B	4.39B	3.97B	3.21B	2.51B	2.7B	1.16B	1.09B	988.39M	988.39M	988.39M	912.51M	723.91M	723.91M	723.91M	676.17M	589.92M	589.92M
Net Income	3.25B	3.14B	1.53B	1.54B	1.43B	3.51B	3.58B	3.08B	3.67B	3.26B	2.55B	2.04B	2.17B	933.34M	869.27M	796.71M	796.71M	796.71M	730.77M	580.76M	580.76M	580.76M	534.95M	473.05M	473.05M
Selling & General & Admin	5.81B	5.3B	2.45B	2.69B	2.75B	6.16B	7.23B	6.85B	6.96B	5.6B	6.03B	5.4B	5.33B	2.37B	1.99B	1.78B	1.78B	1.78B	1.33B	1.06B	1.06B	1.06B	859.79M	748.08M	748.08M
Research & Development	2.73B	2.73B	1.37B	1.3B	1.01B	2.36B	2.28B	2.2B	1.94B	1.64B	1.6B	1.18B	1.09B	500.11M	406.52M	347.62M	347.62M	347.62M	156.87M	n/a	n/a	n/a	77.53M	n/a	n/a
Other Expenses	n/a	1.79M	136.94M	210.44M	16.64M	371.94M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.83B	n/a	-2.12B	-2.12B	-2.12B	n/a	-862.45M	-862.45M	-862.45M	n/a	-653.07M	-653.07M
Operating Expenses	8.54B	8.02B	3.77B	4.02B	3.77B	8.52B	9.51B	9.05B	8.9B	7.24B	7.64B	6.58B	6.42B	35.5M	-2.28B	6.75M	6.75M	6.75M	-1.51B	193.89M	193.89M	193.89M	-917.6M	95.01M	95.01M
Interest Expense	n/a	9.02M	6.16M	6.29M	4.43M	17.02M	11.74M	3.49M	5.74M	7.65M	6.12M	6.14M	31.1M	8.11M	n/a	19.23M	19.23M	19.23M	n/a	5.56M	5.56M	5.56M	-10.91M	9.34M	9.34M
Selling & Marketing Expenses	5.13B	2.11B	2.13B	2.41B	2.49B	2.22B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.18B	1.79B	1.61B	1.61B	1.61B	1.15B	913.87M	913.87M	913.87M	719.31M	624.13M	624.13M
Cost & Expenses	13.52B	12.81B	6B	6.33B	6.31B	13.47B	14.67B	13.21B	12.85B	10.8B	11.11B	9.73B	10.31B	4.38B	-674.01M	3.62B	3.62B	3.62B	73.12M	2.5B	2.5B	2.5B	582.23M	2.18B	2.18B
Income Tax Expense	805.53M	748.85M	341.23M	311.65M	311.86M	738.14M	836.07M	732.49M	664.48M	682.83M	623.73M	493.79M	519.33M	223.2M	220.55M	191.68M	191.68M	191.68M	179.25M	143.15M	143.15M	143.15M	138.44M	116.87M	116.87M
Shares Outstanding (Basic)	11.84B	11.85B	n/a	11.89B	11.92B	11.93B	11.92B	11.95B	11.95B	11.95B	11.95B	11.95B	11.97B	11.96B	11.99B	11.98B	11.98B	11.77B	11.64B	11.62B	11.7B	11.59B	11.54B	11.46B	11.53B
Shares Outstanding (Diluted)	11.84B	11.85B	n/a	11.89B	11.92B	11.93B	11.92B	11.95B	11.96B	11.95B	11.96B	11.95B	11.97B	11.96B	11.99B	11.98B	11.98B	11.98B	11.64B	11.7B	11.7B	11.7B	11.54B	11.53B	11.53B
EPS (Basic)	0.27	0.26	n/a	0.28	0.12	0.29	0.30	0.26	0.31	0.27	0.21	0.17	0.18	0.08	0.07	0.07	0.07	0.07	0.06	0.05	0.05	0.05	0.05	0.04	0.04
EPS (Diluted)	0.27	0.26	n/a	0.28	0.12	0.29	0.30	0.26	0.31	0.27	0.21	0.17	0.18	0.08	0.07	0.07	0.07	0.07	0.06	0.05	0.05	0.05	0.05	0.04	0.04
EBITDA	4.57B	4.42B	1.93B	1.91B	1.79B	4.36B	4.76B	4.32B	4.25B	3.88B	3.21B	2.83B	3B	2.37B	1.2B	2.54B	1.18B	2.17B	1.06B	1.97B	877.16M	877.16M	821.6M	713.52M	728.05M
EBIT	3.98B	1.79B	n/a	1.91B	n/a	2B	1.96B	3.87B	3.72B	3.47B	2.79B	2.44B	2.58B	2.01B	n/a	2.19B	n/a	1.85B	n/a	1.67B	n/a	670.67M	n/a	574.15M	n/a
Depreciation & Amortization	590.95M	630.85M	-39.59K	599.69M	40.26M	634.02M	580.55M	525.44M	515.51M	478.35M	429.28M	394.13M	390.22M	172.9M	-155.75M	163.81M	163.81M	163.81M	-139.95M	149.68M	149.68M	149.68M	-145.43M	131.56M	131.56M